about
The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aeMelanoBase: an online locus-specific variant database for familial melanoma.CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimSAntiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma.Gastric cancer stem cells: evidence, potential markers, and clinical implications.p16INK4a-induced senescence is disabled by melanoma-associated mutationsDroplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood BiopsiesOncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer.Circulating tumour cells--a bona fide cause of metastatic cancer.Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research.The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells.Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition.Clinical outcomes in patients with advanced EGFR-mutated non-small cell lung cancer in South Western Sydney Local Health District.IGFBP7 is not required for B-RAF-induced melanocyte senescence.Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired.The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma.Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.Selective loss of wild-type p16(INK4a) expression in human nevi.Oncogenic B-RAFV600E Promotes Anchorage-Independent Survival of Human MelanocytesWild type and melanoma-associated mutant p16INK4aproteins do not oligomerize in vivoAnalysis of the p16 gene, CDKN2, in 17 Australian melanoma kindredsImmunomagnetic isolation of circulating melanoma cells and detection of PD-L1 statusDetection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and ExosomesThe Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective studyPlasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinibExpression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma
P50
Q24317334-55F45AC2-B4A8-4202-AB7C-3B65AB99ADCFQ30877598-D3206B8C-80A8-41BB-825A-91FBCB06341CQ33755286-593F4AE3-F15E-4278-B8BB-4ACC32CAEA38Q34545490-2D7CFD1C-8A2A-4E4D-8BE8-BBCDFCF5EB9BQ34651442-3E7677F9-B670-4E6F-BF91-E22224B5D922Q35795934-34A38C29-F3E5-4BA9-AAAD-06F0200DDCA3Q36971412-90F910D6-4422-4167-AD8E-4566DCF08102Q37210010-DA4F92AA-CEA7-4375-AF3F-62E2EEDADE3AQ37210779-E5AEA5A6-7127-4F5D-A70A-05CE059491E7Q38152315-67509B10-5CEB-4ECB-82C1-801B44F4AE86Q38173798-FBFA715D-67A3-4CA0-90D0-64D36BD0525FQ38210937-7A0D4A75-B1D8-4B29-ADEA-A1500C264A60Q38227766-C7507620-1570-4216-95FD-2DD687E430E4Q38280399-1159A140-70B6-4C6E-9677-54D51E1E7135Q38734713-F04AD73D-B921-42C1-9191-5BC6600C69D4Q38833520-041D0259-C9CB-4666-93B1-F821AE1C8517Q39030603-AA05D612-5143-40DE-91F9-2570F025CA27Q39167351-F8EFE084-2E3B-461C-AF20-F1DEE6E9ED84Q39375855-15880063-BF8A-41C8-9A69-363A0879884DQ39457284-BD9E4CAC-FE17-4D0E-B94D-D43ACA93108EQ39703150-A80B6523-53E4-46F0-A172-4A52442F94CCQ39722414-D670B542-8B41-4C09-8BAB-6E2309EC4464Q39884649-56C64706-6870-4805-B817-DB65926D563EQ40411801-1B88ACCE-EDAB-4A5C-B381-1B8A85C8820EQ44073293-8DE51A81-2926-4615-91D7-CC5E0D1335AAQ50317499-A3CE2741-4A88-4B40-AAC5-335B8E4A738DQ52526628-D644215D-1F80-44D0-B37C-55A13ADDBB0FQ53438251-EB243970-F330-4360-B7A4-B1F2A4553A89Q54576054-595B6F54-5554-4820-80A5-1F935A43C147Q58024781-31F44366-45D9-4C02-944E-D9416C5BABF2Q58024836-1111F4A6-5AFB-4852-A153-7E5E14B53F41Q58024987-1CFA5BD5-9FBC-418E-AFDC-77FFF72CB53EQ64234580-C7B0B092-3A9C-4437-8334-8B79C62E7B58Q91746701-E9315A2B-DC34-441B-A075-B0D500E95400Q91943954-60D0AAAB-0D06-4991-A2B0-9F82E52EB9EFQ91997911-64DE029E-5FEC-4BEB-A547-971687C36984Q92633734-70AFED13-3132-4A20-91ED-85BC5AE1C6DFQ92967857-B95A3F0C-122C-4F22-B9CE-E02879744A36
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Therese Becker
@ast
Therese Becker
@en
Therese Becker
@es
Therese Becker
@nl
type
label
Therese Becker
@ast
Therese Becker
@en
Therese Becker
@es
Therese Becker
@nl
prefLabel
Therese Becker
@ast
Therese Becker
@en
Therese Becker
@es
Therese Becker
@nl
P106
P31
P496
0000-0002-5636-9902